Pulsesight Therapeutics
Industry
- Biotechnology
- Large Molecule
- Gene Therapy, Cell Therapy
- Pharmaceuticals
- Drug Delivery
- Medical Devices
Other Names/Subsidiaries
- Eyevensys SAS
Latest on Pulsesight Therapeutics
Venture capital investment in biopharmaceutical companies has been remarkable throughout 2020, both in terms of individual company fundraisings and new VC funds, including two funds totaling $755m tha
Funding for start-ups and other early-stage companies continues to flow into the biopharmaceutical industry from new and established sources. That includes Novo Holdings’ REPAIR Impact Fund, which has
Boehringer Ingelheim GMBH prides itself on early-stage deal making but in some cases the groundwork has been done years in advance by the German company's venture capital arm. "Our goal is to look at
Eli Lilly & Co. has announced that Kimberly Blackwell will join Lilly Oncology as vice president of early phase development and immuno-oncology in March 2018. She is currently professor of medic